Dornier MedTech company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

dornier.com

Stage

Other Investors | Alive

About Dornier MedTech

Dornier Medtech America is a medical device company. It had developed the Medilas D Family Lasers, Including Medilas D Litebeam, Litebeam +, Urobeam, Multibeam, Flexipulse And Magnapulse.Dornier MedTech develops, manufacturers, markets and services lithotripters, orthopedic shock wave devices, urotables and medical aesthetic lasers worldwide, providing innovative therapeutic, diagnostic and service solutions for numerous healthcare fields. Dornier MedTech invented extracorporeal shockwave lithotripsy, (ESWL), more than 25 years ago for the disintegration of kidney stones, which is today the gold standard for urinary stone treatment.

Dornier MedTech Headquarter Location

1155 Roberts Blvd.

Kennesaw, Georgia, 30144,

United States

770-426-1315

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Dornier MedTech Patents

Dornier MedTech has filed 13 patents.

The 3 most popular patent topics include:

  • Medical equipment
  • Acoustics
  • Digestive system procedures
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/24/2014

4/16/2019

Laser science, Spectroscopy, Laser applications, Nonlinear optics, Laser medicine

Grant

Application Date

10/24/2014

Grant Date

4/16/2019

Title

Related Topics

Laser science, Spectroscopy, Laser applications, Nonlinear optics, Laser medicine

Status

Grant

Latest Dornier MedTech News

Endoluxe to Exhibit With Dornier Medtech During American Urology Association Conference in New Orleans May 13-16, 2022

Apr 7, 2022

April 07, 2022 01:41 PM Eastern Daylight Time MANHATTAN BEACH, Calif.--( BUSINESS WIRE )--Endoluxe is proud to announce that they will be part of the Dornier MedTech exhibition booth during the upcoming AUA conference in New Orleans. Dornier and Endoluxe have products and platforms focused in the urology arena offering innovation and value. “Our goal in inventing the Endoluxe EVS was to eliminate the costly, complicated and antiquated pieces of legacy endoscopy video platforms,” states co-founder Dr. Neal Patel. “We designed a platform that accommodates innovations which enhance procedure adoption, patient safety, and clinical outcomes. Dornier is an excellent partner to work with at the AUA and we appreciate their support of our platform.” The Endoluxe EVS is the perfect camera system for all endoscopic procedures that utilize industry standard rigid and flexible analogue scopes such as urology, gynecology, ENT, general surgery, and orthopedics. The handheld Orb replaces the legacy endoscopic tower with advanced, portable technology at 1/6 the cost. “We are pleased to have Endoluxe represented in our AUA booth and believe their technology represents the future of endoscopic visualization. With the various new innovative urology products that Dornier is introducing at AUA, it is an ideal situation to have Endoluxe join our exhibit,” states Brock Faulkner, general manager of Dornier MedTech. Endoluxe is a world-class endoscopic video imaging organization based in the United States with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices, while taking advantage of future technological advancements utilizing our portable, integrated, and feature-laden platform at 1/6th the cost of legacy products. More information can be found at Endoluxe.com . Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech. As a pioneer in the field of urology, Dornier is one of the most trusted names in the industry. Dornier continues to spearhead innovation in urology, launching more than 25 urology device innovations in the last 5 years. It is pushing the envelope in digital urology to provide holistic care to patients who are seeking treatment and community as they work through their conditions online and in real life. For more information, visit www.dornier.com . Contacts

Dornier MedTech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Dornier MedTech Rank

  • Where is Dornier MedTech's headquarters?

    Dornier MedTech's headquarters is located at 1155 Roberts Blvd., Kennesaw.

  • What is Dornier MedTech's latest funding round?

    Dornier MedTech's latest funding round is Other Investors.

  • Who are Dornier MedTech's competitors?

    Competitors of Dornier MedTech include AlterG, PartsSource, Symetrica, Digirad, TrueVision Systems and 11 more.

You May Also Like

A
Advanced Medical Diagnostics

Advanced Medical Diagnostics appoints Imaging Equipment Ltd as commercial agent for Prostate HistoScanning in the UK and Ireland.

A
Abilities MedTec

Abilities MedTec manufactures and distributes durable medical equipment (DME) in the United States. The product is a multi-lifting device that aims to provide people with mobility beyond their wheelchair. Per the company, the same lift can also transfer equipment such as scooters and power chairs.

Tears for Life Logo
Tears for Life

Tears For Life, a medical diagnostic equipment company currently developing a non-invasive tear test kit that will be able to screen women for breast cancer using proteins found in their tears.

N
Navotek Medical

Navotek Medical is a developer of the proprietary RealTrack intra-body tracking technology

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

C
CardioQuickSys

CardioQuickSys is a rapidly growing company in the medical equipment arena. They are focused on delivering cardiac-related products that provide practical new ways to improve patient outcomes.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.